J04.0: Acute laryngitis
J04.0 is a billable, specific ICD-10-CM code for acute laryngitis. It is valid for submission on a claim.
Check J04.0 with the rest of the claim: free scrubberExcludes1: never code together
These conditions cannot occur together. Billing both on the same encounter is a denial.
- acute obstructive laryngitis (J05.0)
Excludes2: not included here, but may coexist
The excluded condition is not part of this code, but a patient can have both. You may code both.
- chronic laryngitis (J37.0)
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Edematous laryngitis (acute)
- Laryngitis (acute) NOS
- Subglottic laryngitis (acute)
- Suppurative laryngitis (acute)
- Ulcerative laryngitis (acute)
Excludes1 inherited from the categories above J04.0
A category’s note binds every code beneath it.
Excludes2 inherited from the categories above J04.0
Not part of this code, but both may be coded when both are present.
Other codes that can never be billed with J04.0
Their own Excludes1 notes name this code, so the conflict is not listed above.
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Medicare coverage
J04.0 is named in 5 Medicare coverage policies: 5 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A54111Billing and Coding: Speech Language Pathology (SLP) Services: Communication Disorders
- A57205Billing and Coding: Oximetry Services
- A58575Billing and Coding: Respiratory Pathogen Panel Testing
- A58577Billing and Coding: Respiratory Pathogen Panel Testing
Alphabetic index entries that lead here
- Glottitis
- Laryngitis(acute) (edematous) (fibrinous) (infective) (infiltrative) (malignant) (membranous) (phlegmonous) (pneumococcal) (pseudomembranous) (septic) (subglottic) (suppurative) (ulcerative)
- Gangrene, gangrenous›laryngitis
- Laryngitis›H. influenzae
- Laryngitis›Hemophilus influenzae
- Laryngitis›streptococcal
- Laryngitis›spasmodic›acute
Code history
Unchanged in every release from FY2024 to FY2027.